SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ | 477,380 | $13,163 | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 60,983 | $1,681 | 0.00% |
| Handelsbanken Fonder AB | 12,416 | $342 | 0.00% |
| Citadel Advisors | 375,826 | $10,361,522 | 0.00% |
| Ensign Peak Advisors, Inc | 26,146 | $720,845 | 0.00% |
| DekaBank Deutsche Girozentrale | 31,775 | $888 | 0.00% |
| PSI Advisors, LLC | 190 | $5,238 | 0.00% |
| J.P. Morgan Private Wealth Advisors LLC | 12,830 | $353,725 | 0.00% |
| D. E. Shaw & Co., Inc. | 25,023 | $689,884 | 0.00% |
| GOLDMAN SACHS GROUP INC | 157,310 | $4,337,036 | 0.00% |
| MORGAN STANLEY | 528,579 | $14,572,922 | 0.00% |
| Man Group plc | 11,319 | $312,065 | 0.00% |
| PRIVATE TRUST CO NA | 288 | $7,940 | 0.00% |
| OSAIC HOLDINGS, INC. | 12,818 | $353,338 | 0.00% |
| Allianz Asset Management GmbH | 14,700 | $405,279 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 355,002 | $9,787,405 | 0.00% |
| Gladius Capital Management LP | 955 | $26,330 | 0.00% |
| Key FInancial Inc | 122 | $3,364 | 0.00% |
| Parkside Financial Bank & Trust | 183 | $5,046 | 0.00% |
| ALLIANCEBERNSTEIN L.P. | 62,818 | $1,731,892 | 0.00% |
External links
This page lists SUPERNUS PHARMACEUTICALS INC's shareholders in Q3 2023. To view SUPERNUS PHARMACEUTICALS INC's shareholder history, click here.